Swiss National Bank boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 188,400 ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

We recently published a list of Top 10 Stocks to Buy According to 12 West Capital Management. In this article, we are going ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Analyzing the results of companies we own in this space, 10X Genomics (TXG), Cryoport (CYRX) and Bio-Techne (TECH), as well as peers like Thermo Fisher Scientific, Danaher and large CDMOs like ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Founded in 2012, 10x Genomics (NASDAQ:TXG) is a biotech company developing gene-sequencing solutions based in the US. In a rather competitive market, TXG’s focus has been on single-cell and ...

As of 4 March at 10:19:35 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent ...